| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
American HealthChoice, Inc. is a Flower Mound, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ARKRAY USA is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Most Products Inc is a Plainwell, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We aim to make personalized brain health a reality.For everyone. Linus Health integrates the latest in cutting-edge neuroscience and AI technology with everyday digital tools to give individuals and their care professionals up-to-the-minute brain healt...